Advertisement

Topics

Silenseed Phase II pancreatic cancer drug trial to begin

07:32 EDT 30 Jul 2017 | Globes

The Israeli company is raising $10 million in order to help conduct the trial.

Original Article: Silenseed Phase II pancreatic cancer drug trial to begin

NEXT ARTICLE

More From BioPortfolio on "Silenseed Phase II pancreatic cancer drug trial to begin"

Quick Search
Advertisement